HROW
Closed
Harrow Health Inc
30.77
+0.23 (+0.75%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 30.54
Day's Range: 29.78 - 30.855
Send
sign up or login to leave a comment!
When Written:
21.14
Harrow Health Inc. is a pharmaceutical company that focuses on developing and commercializing innovative and affordable medications for various diseases and medical conditions. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
Harrow Health's portfolio includes a range of ophthalmic and injectable drugs, as well as products for pain management, dermatology, and women's health. The company also has a subsidiary, ImprimisRx, which specializes in compounded medications.
Harrow Health is committed to improving patient access to affordable medications and has developed a unique business model that allows it to offer high-quality drugs at lower prices than traditional pharmaceutical companies. The company works closely with healthcare providers, payers, and patients to ensure that its products meet their needs and are accessible to all.
In addition to its commercial activities, Harrow Health is also involved in research and development, with a focus on developing new drugs and improving existing ones. The company has a strong commitment to innovation and is constantly exploring new ways to improve patient outcomes and reduce healthcare costs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Harrow Health's portfolio includes a range of ophthalmic and injectable drugs, as well as products for pain management, dermatology, and women's health. The company also has a subsidiary, ImprimisRx, which specializes in compounded medications.
Harrow Health is committed to improving patient access to affordable medications and has developed a unique business model that allows it to offer high-quality drugs at lower prices than traditional pharmaceutical companies. The company works closely with healthcare providers, payers, and patients to ensure that its products meet their needs and are accessible to all.
In addition to its commercial activities, Harrow Health is also involved in research and development, with a focus on developing new drugs and improving existing ones. The company has a strong commitment to innovation and is constantly exploring new ways to improve patient outcomes and reduce healthcare costs.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








